लोड हो रहा है...
Engineered herpes simplex viruses efficiently infect and kill CD133+ human glioma xenograft cells that express CD111
Oncolytic herpes simplex viruses (HSV) hold promise for therapy of glioblastoma multiforme (GBM) resistant to traditional therapies. We examined the ability of genetically engineered HSV to infect and kill cells that express CD133, a putative marker of glioma progenitor cells (GPC), to determine if...
में बचाया:
| में प्रकाशित: | J Neurooncol |
|---|---|
| मुख्य लेखकों: | , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2009
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4574288/ https://ncbi.nlm.nih.gov/pubmed/19521665 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-009-9926-0 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|